Abstract:Objective: To figure out the effect of somatostatin analogue Octreotide on proliferation and invasion of human hepatocellular carcinoma cell MHCC97-H and the underlying mechanism in vitro and in vivo. Methods: MHCC97-H cells were treated with Octreotide at the concentration of 0.2 ug/mL in vitro, proliferation related to time was evaluated. After treated with Octreotide at the concentration of 0.2 ug/mL for 48 h, MHCC97-H cells were observed by transmission electron microscope. Cell proliferation was detected by MTT assay after MHCC97-H cells were treated with Octreotide at different concentrations including 0.05, 0.1, 0.2, 0.4, 0.6 and 0.8 ug/mL for 36 h in vitro. 27 nude mice, in which MHCC97-H tumor mass was planted orthotopically, were divided into 3 groups randomly including control group （intraperitoneal injection with equal volume normal saline; n=8）, low dose treated group （intraperitoneal injection with Octreotide at 50 ug/kg?d; n=9） and large dose treated group （intraperitoneal injection with Octreotide at 200 ug/kg?d; n=10）. All mice were raised for 35 d and sacrificed. The information about survival time, the weight at death point and the pathology change of liver and lung was collected. The expression of vascular endothelial growth factor （VEGF） and matrix metalloproteinases-2 （MMP-2） in mouse HCC tissues were detected by immunohistochemistry finally. Results: MTT assays showed that Octreotide inhibited the proliferation of MHCC97-H cells significantly. Apoptosis cells were found by transmission electron microscope after treatment with Octreotide at 0.2 ug/mL for 48 h in vitro. The proliferation was inhibited significantly by Octreotide in a dose-dependant manner （r=0.86, P＜0.01）. Compared with control group, the treated group had the heavier weight at death point and lower intrahepatic metastasis ratio （P＜0.05）, meanwhile, there was not significant difference in treated groups （P＞0.05）. The positive expression ratios of VEGF and MMP-2 in treated groups were lower than those in control group （P＜0.05）, while there was no apparent difference in treated groups （P＞0.05）. Conclusion: Octreotide could inhibit the proliferation of MHCC97-H cells in vitro via inducing apoptosis and the inhibitory function acts in a dose-dependant manner. Octreotide could improve survival of mice with MHCC97-H cells and inhibit the metastasis of MHCC97-H cells in vivo. Regulation of VEGF and MMP-2 expression by Octreotide would be involved in its inhibition in vivo.

Effect of Octreotide on Pancreatic Cancer Cells Transfected with SST 2 Gene

Effect of Octreotide on Human Pancreatic Cancer Cells after Transfected with Somatostatin Receptor Type 2 Gene

Regulation of Survivin Induced by Octreotide in Pancreatic Cancer Cells

The effects of Octreotide on proliferation、apoptosis and VEGF expression in human pancreatic cancer cell line

Effect of octreotide on cell proliferation in pancreatic adenocarcinoma

Octreotide Inhibits Proliferation and Invasion of MHCC97-H Cells in Vitro and in Vivo

Mechanism of octreotide reversing multidrug resistance in human pancreatic cancer cell line BxPC - 3

Octreotide Inhibits Proliferation and Induces Apoptosis of Hepatocellular Carcinoma Cells.

Effect of Octreotide on human hepatocellular cancer cell line MHCC97-H in vitro

The Apoptosis of Human Hepatocellular Carcinoma Cells Mediated by Somatostatin Receptor Subtypes

Anti-carcinoma Effect of Targeted Radiotherapy Using 90Y-Dota-octreotide Mediated by Somatostatin Receptor

Inhibitory Effect of Octreotide on the Growth of Gastric Cancer in vivo and in vitro

The Effect of Octreotide on Growth Inhibition of Subcutaneous Implanted Tumor with Human Gallbladder Carcinoma in Nude Mice

The Effect of Octreotide on Proliferation and P-glycoprotein Expresslon of SGC-7901 Cell Line

Effects of Octreotide on Necrosis of Hepatocellular Carcinoma Xenografts in Nude Mice

Octreotide Stimulates Somatostatin Receptor-Induced Apoptosis of SW480 Colon Cancer Cells by Activation of Glycogen Synthase Kinase-3Β, A Wnt/β-catenin Pathway Modulator.

Effect of Octreotide on Angiogenesis Induced by Hepatocellular Carcinoma in Vivo

Hsstr 2 Expression and Octreotide Treatment Reverses Multidrug Resistance of BxPC-3 Human Pancreatic Cancer Cells

Effect of octreotide on transforming growth factor-alpha in human hepatocellular carcinoma cells

[Mechanisms of Inhibition of Growth of Human Pancreatic Carcinoma Implanted in Nude Mice by Somatostatin Receptor Subtype 2].

Octreotide effects on the proliferation and apoptosis of hepatic stellate cells